← back to search

Huan Meng

Jiangsu University · CN
Area of research
Biomedical Engineering · Biomaterials
Research interest
Research interests include Nanoparticle-Based Drug Delivery, Nanoparticles: synthesis and applications, Nanoplatforms for cancer theranostics, and Graphene and Nanomaterials Applications.
h-index
71
citations
23,276
works
210
NIH funding
primary concept
email

Recent publications

Engineering inhalable nanomedicines to navigate lung barriers for effective pulmonary fibrosis therapy
Nano Today 2025cited by 6position: lastdoi
Transcytotic transportation of size-controlled nanocarriers into dystrophic skeletal muscle leads to therapeutic outcome in mice
Nature Communications 2025cited by 4position: lastdoi
Amplification-free CRISPR/Cas12a biosensor integrating AuNPs-mediated surface plasmon resonance for human papillomavirus detection and genotyping
Biosensors and Bioelectronics 2025cited by 4position: middledoi
The safety of trastuzumab deruxtecan (DS‐8201) with a focus on interstitial lung disease and/or pneumonitis: A systematic review and single‐arm meta‐analysis
Cancer 2024cited by 15position: middledoi
Pulmonary Delivery of Specialized Pro-Resolving Mediators-Based Nanotherapeutics Attenuates Pulmonary Fibrosis in Preclinical Animal Models
ACS Nano 2023cited by 24position: lastdoi
Cost–benefit analysis of nanofertilizers and nanopesticides emphasizes the need to improve the efficiency of nanoformulations for widescale adoption
Nature Food 2022cited by 120position: middledoi
Determination of the nanoparticle- and cell-specific toxicological mechanisms in 3D liver spheroids using scRNAseq analysis
Nano Today 2022cited by 30position: middledoi
Combination Chemo‐Immunotherapy for Pancreatic Cancer Using the Immunogenic Effects of an Irinotecan Silicasome Nanocarrier Plus Anti‐PD‐1
Advanced Science 2021cited by 132position: lastdoi
Development of Facile and Versatile Platinum Drug Delivering Silicasome Nanocarriers for Efficient Pancreatic Cancer Chemo‐Immunotherapy
Small 2021cited by 72position: lastdoi
Disrupting tumour vasculature and recruitment of aPDL1-loaded platelets control tumour metastasis
Nature Communications 2021cited by 70position: middledoi
Nanocellulose Length Determines the Differential Cytotoxic Effects and Inflammatory Responses in Macrophages and Hepatocytes
Small 2021cited by 63position: middledoi
Injectable Biodegradable Polymeric Complex for Glucose-Responsive Insulin Delivery
ACS Nano 2021cited by 56position: middledoi
Liposomal Delivery of Mitoxantrone and a Cholesteryl Indoximod Prodrug Provides Effective Chemo-immunotherapy in Multiple Solid Tumors
ACS Nano 2020cited by 166position: middledoi
Lateral size of graphene oxide determines differential cellular uptake and cell death pathways in Kupffer cells, LSECs, and hepatocytes
Nano Today 2020cited by 84position: middledoi
Safety Considerations of Cancer Nanomedicine—A Key Step toward Translation
Small 2020cited by 80position: lastdoi
Use of ratiometrically designed nanocarrier targeting CDK4/6 and autophagy pathways for effective pancreatic cancer treatment
Nature Communications 2020cited by 68position: lastdoi
Oxygen-independent free radical generation mediated by core-shell magnetic nanocomposites synergizes with immune checkpoint blockade for effective primary and metastatic tumor treatment
Nano Today 2020cited by 18position: middledoi
Use of lung-specific exosomes for miRNA-126 delivery in non-small cell lung cancer
Nanoscale 2019cited by 228position: middledoi
Transcytosis - An effective targeting strategy that is complementary to “EPR effect” for pancreatic cancer nano drug delivery
Theranostics 2019cited by 151position: lastdoi
Use of Polymeric Nanoparticle Platform Targeting the Liver To Induce Treg-Mediated Antigen-Specific Immune Tolerance in a Pulmonary Allergen Sensitization Model
ACS Nano 2019cited by 119position: middledoi
Breast Cancer Chemo-immunotherapy through Liposomal Delivery of an Immunogenic Cell Death Stimulus Plus Interference in the IDO-1 Pathway
ACS Nano 2018cited by 226position: middledoi
Walking the line: The fate of nanomaterials at biological barriers
Biomaterials 2018cited by 183position: firstdoi
Improved Efficacy and Reduced Toxicity Using a Custom-Designed Irinotecan-Delivering Silicasome for Orthotopic Colon Cancer
ACS Nano 2018cited by 126position: lastdoi
Use of nano engineered approaches to overcome the stromal barrier in pancreatic cancer
Advanced Drug Delivery Reviews 2018cited by 91position: firstdoi
Diverse Applications of Nanomedicine
ACS Nano 2017cited by 1,327position: middledoi
Nano-enabled pancreas cancer immunotherapy using immunogenic cell death and reversing immunosuppression
Nature Communications 2017cited by 437position: middledoi
New Insights into “Permeability” as in the Enhanced Permeability and Retention Effect of Cancer Nanotherapeutics
ACS Nano 2017cited by 297position: lastdoi
Tumor-penetrating peptide enhances transcytosis of silicasome-based chemotherapy for pancreatic cancer
Journal of Clinical Investigation 2017cited by 220position: lastdoi
Irinotecan Delivery by Lipid-Coated Mesoporous Silica Nanoparticles Shows Improved Efficacy and Safety over Liposomes for Pancreatic Cancer
ACS Nano 2016cited by 262position: lastdoi
Plasmonic Copper Sulfide Nanocrystals Exhibiting Near-Infrared Photothermal and Photodynamic Therapeutic Effects
ACS Nano 2015cited by 607position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

André E. Nel · California NanoSystems Institute25 papers (2012–2022)Yu‐Pei Liao · California NanoSystems Institute18 papers (2012–2021)Tian Xia · Berkeley College18 papers (2012–2023)Chong Hyun Chang · Hainan University17 papers (2012–2022)Xiangsheng Liu · Zhejiang Cancer Hospital16 papers (2016–2025)Jinhong Jiang · Southwest Petroleum University12 papers (2017–2025)Zhaoxia Ji · Anyang Tumor Hospital11 papers (2012–2015)Sijie Lin · Tongji University11 papers (2012–2015)Haiyuan Zhang · Harbin Institute of Technology10 papers (2012–2015)Jiulong Li · National Center for Nanoscience and Technology7 papers (2020–2025)Ying Ji · Harbin Normal University7 papers (2018–2021)Jeffrey I. Zink · University of California, Los Angeles7 papers (2012–2014)Bingbing Sun · Sun Yat-sen University7 papers (2012–2017)Xiang Wang · City University of Hong Kong6 papers (2012–2014)Kuo‐Ching Mei · University of North Carolina at Chapel Hill5 papers (2019–2021)Ruibin Li · Hebei Medical University5 papers (2012–2015)Qi Liu · Beihang University5 papers (2019–2021)Zev A. Wainberg · UCLA Medical Center4 papers (2017–2021)Ivanna Tang · Creighton University4 papers (2018–2021)Jianqin Lu · University of Arizona4 papers (2017–2019)